BSLN — Basilea Pharmaceutica AG Allschwil Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣600.87m
- CH₣554.48m
- CH₣208.54m
- 69
- 64
- 80
- 87
Annual cashflow statement for Basilea Pharmaceutica AG Allschwil, fiscal year end - December 31st, CHF millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -14.7 | -6.83 | 12.1 | 10.5 | 77.6 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | -9.84 | 5.84 | 5.54 | 6.53 | 6.08 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -30.8 | -31.8 | -11.7 | -4.32 | 6.29 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -54.1 | -32 | 7.06 | 14.2 | 74.4 |
| Capital Expenditures | -2.27 | -0.86 | -3.3 | -1.03 | -1.79 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -32.7 | 4.43 | 95 | 0 | 0.781 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -35 | 3.58 | 91.6 | -1.03 | -1.01 |
| Financing Cash Flow Items | -3.19 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 45.1 | 16.6 | -45.2 | -57.3 | -13.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -44.8 | -11.3 | 53.6 | -44.2 | 60.2 |